Sen Zhang

4.5k total citations · 1 hit paper
168 papers, 2.8k citations indexed

About

Sen Zhang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Sen Zhang has authored 168 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 30 papers in Oncology and 26 papers in Surgery. Recurrent topics in Sen Zhang's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Sen Zhang is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Sen Zhang collaborates with scholars based in China, United States and Hong Kong. Sen Zhang's co-authors include Xiaoguang Chen, Zhaojun Li, Yuanyuan Chen, Guanhua Du, Dongming Zhang, Xiangtian Zhou, Jingzhi Yang, Weida Wang, Xuan Zhou and Sheng Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sen Zhang

153 papers receiving 2.7k citations

Hit Papers

Long non-coding RNAs: From disease code to drug role 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sen Zhang China 29 1.4k 613 332 323 301 168 2.8k
Lu Gao China 30 1.4k 1.1× 712 1.2× 146 0.4× 257 0.8× 254 0.8× 143 2.8k
Nehal M. Elsherbiny Egypt 36 1.2k 0.8× 257 0.4× 226 0.7× 304 0.9× 218 0.7× 114 3.2k
Jiyoung Kim South Korea 28 1.4k 1.0× 412 0.7× 516 1.6× 255 0.8× 175 0.6× 78 2.6k
Jun Zeng China 27 1.3k 0.9× 282 0.5× 287 0.9× 380 1.2× 220 0.7× 112 2.4k
Bei Sun China 33 1.4k 1.1× 403 0.7× 344 1.0× 428 1.3× 203 0.7× 141 3.6k
Jong Hyun Lee South Korea 32 1.6k 1.2× 504 0.8× 678 2.0× 336 1.0× 170 0.6× 94 2.9k
Dan Meng China 29 1.7k 1.2× 391 0.6× 204 0.6× 183 0.6× 298 1.0× 109 2.7k
Po‐Len Liu Taiwan 31 1.4k 1.0× 410 0.7× 174 0.5× 210 0.7× 299 1.0× 79 2.8k
Mingyuan Wu China 30 977 0.7× 170 0.3× 442 1.3× 411 1.3× 395 1.3× 107 3.8k

Countries citing papers authored by Sen Zhang

Since Specialization
Citations

This map shows the geographic impact of Sen Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sen Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sen Zhang more than expected).

Fields of papers citing papers by Sen Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sen Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sen Zhang. The network helps show where Sen Zhang may publish in the future.

Co-authorship network of co-authors of Sen Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sen Zhang. A scholar is included among the top collaborators of Sen Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sen Zhang. Sen Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Sen, Jie Wang, Bing Feng, et al.. (2025). Cost-effectiveness of CDK4/6 inhibitors for second-line HR+/HER2− advanced or metastatic breast cancer in China. Scientific Reports. 15(1). 12765–12765. 2 indexed citations
2.
Huang, Leaf, et al.. (2025). Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models. Biochemical Genetics. 64(1). 660–683. 1 indexed citations
3.
Geng, Zhi, et al.. (2025). Distinct roles of A1/A2 astrocytes in blood-brain barrier injury following cerebral I/R via the ROCK/NF-κB and STAT3 pathways. International Immunopharmacology. 151. 114338–114338. 2 indexed citations
4.
Zhang, Sen, Li Wan, Yizhi Zhang, et al.. (2025). Kaempferol promotes angiogenesis through HIF-1α/VEGF-A/Notch1 pathway in ischemic stroke rats. Neurochemistry International. 185. 105953–105953. 5 indexed citations
5.
Wang, Ting, Kai Chen, Dali Yin, et al.. (2024). Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation. Bioorganic Chemistry. 152. 107740–107740. 2 indexed citations
6.
Zhang, Sen, et al.. (2024). White feces syndrome is closely related with hypoimmunity and dysbiosis in Litopenaeus vannamei. Aquaculture Reports. 38. 102329–102329. 1 indexed citations
7.
Yan, Min, Sen Zhang, Xing Jiang, et al.. (2024). SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options. Brain Research Bulletin. 213. 110988–110988. 15 indexed citations
8.
Zhang, Sen, Kai Ma, Kunjing Pang, et al.. (2024). Ozaki technique versus Ross operation for complex aortic valve diseases in children: a retrospective cohort study. International Journal of Surgery. 111(1). 113–121. 1 indexed citations
9.
Wu, Hao, Yuanyuan Wang, Weihe Zhou, et al.. (2024). Short-term choroidal changes as early indicators for future myopic shift in primary school children: results of a 2-year cohort study. British Journal of Ophthalmology. 109(2). 273–280. 2 indexed citations
10.
Wan, Peng, et al.. (2024). Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma. World Journal of Clinical Oncology. 15(7). 859–866. 2 indexed citations
11.
Shi, Xiaohu, Yingda Zang, Xiaodi Zhao, et al.. (2023). 7-hydroxycoumarin-β-D-glucuronide protects against cisplatin-induced acute kidney injury via inhibiting p38 MAPK-mediated apoptosis in mice. Life Sciences. 327. 121864–121864. 11 indexed citations
12.
Su, Zhanhao, Keming Yang, Kai Ma, et al.. (2023). Biopsy-detected myocardial fibrosis predicts adverse cardiac events after pulmonary valve replacement in patients with repaired tetralogy of Fallot. Interdisciplinary CardioVascular and Thoracic Surgery. 36(3). 4 indexed citations
13.
Wang, Weida, Mingjin Wang, Tingting Du, et al.. (2023). SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling. International Journal of Molecular Sciences. 24(8). 7150–7150. 18 indexed citations
14.
Wang, Peng, et al.. (2023). The effect of nutritional biochemical indexes on the hospitalization outcome of COVID-19. Aging. 15(23). 14445–14456.
15.
Ren, Liwen, Xiangjin Zheng, Jinyi Liu, et al.. (2021). Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle. Acta Pharmacologica Sinica. 43(1). 194–208. 60 indexed citations
16.
Pan, Miaozhen, Fei Zhao, Hao Wu, et al.. (2021). Dietary ω-3 polyunsaturated fatty acids are protective for myopia. Proceedings of the National Academy of Sciences. 118(43). 62 indexed citations
17.
Li, Jian‐Ping, et al.. (2019). Effect and mechanism of Huangkui capsule on reduction of uremic toxin accumulation in an animal model of chronic kidney disease.. Yaoxue xuebao. 54(12). 2267–2276. 3 indexed citations
18.
Zhang, Sen, Dongjie Wang, Nina Xue, et al.. (2017). Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling.. PubMed Central. 9(1). 115–125. 12 indexed citations
19.
Zhang, Sen. (2000). CONSTITUTION AND METAMORPHISM OF THE SONGDUO GROUP IN THE SOUTH MARGIN OF GANDISE-B TYPE MOUNTAIN CHAIN IN TIBET. 1 indexed citations
20.
Zhang, Sen. (2000). Analgesic efficacy of diclofenac potassium in dental pain trial. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026